Sector consensus Forte Biosciences, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-08-14 EDT			5-day change	1st Jan Change
76.83 ^USD	-0.04%		+0.05%	+181.74%

08-12	Forte Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-06	European Stocks Close Mixed in Thursday Trading, Investors Monitor Iran Deal Talks	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
FORTE BIOSCIENCES, INC.			73.8	-3.94%	5
WUXI APPTEC CO., LTD.			182.53	+14.63%	18
ARGENX SE	-	-	1,229.81	+45.47%	1
INSMED INCORPORATED			200.05	+61.67%	22
WUXI BIOLOGICS (CAYMAN) INC.			40.85	+5.3%	23
BIONTECH SE			104.26	+29.48%	20
PHARMAESSENTIA CORPORATION			1,216.34	-18.91%	7
GENMAB A/S			2,410.59	+18.92%	15
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.			570.05	+9.52%	18
EXELIXIS, INC.			52.94	+3.31%	16
ARROWHEAD PHARMACEUTICALS, INC.			110.18	+27.17%	11
MADRIGAL PHARMACEUTICALS, INC.			678.06	+33.59%	16
AKESO, INC.			144.21	+74.81%	21
SUMMIT THERAPEUTICS INC.			21.11	+113.53%	13
CYTOKINETICS, INCORPORATED			109.9	+48.25%	20
SPYRE THERAPEUTICS, INC.			124.71	+20.35%	14
REMEGEN CO., LTD.			99.56	+43.57%	16
CRINETICS PHARMACEUTICALS, INC.			85.5	+0.94%	10
VAXCYTE, INC.			109	+87.7%	9
SHANGHAI ALLIST PHARMACEUTICALS CO., LTD.	-	-	-	-	-
Average			398.08	+32.39%	14
Weighted average by Cap.			507.1	+29.93%	14